News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Novartis
NEWS
JOBS
IN THE PRESS
NEWS
Genetown
Novartis AG Is Challenging Biogen On Biogen’s Own Turf
October 27, 2016
·
1 min read
Biotech Bay
Novartis AG CEO Thinks The Drug Pricing Debate Will Get “More Difficult” In The Next 3-5 Years
October 26, 2016
·
1 min read
Job Trends
This is Why Novartis AG Folded Its CAR-T Unit
October 26, 2016
·
3 min read
Deals
Novartis AG Has Up to $5 Billion Burning in Its Pocket for M&As
October 26, 2016
·
1 min read
Deals
Merck & Co. and Novartis AG CEOs Blueprint What’s on Their M&A Wish List for 2017
October 26, 2016
·
2 min read
Business
Watch Out Juno and Kite Pharma: Novartis AG Clearly Not Done With CAR-T
October 25, 2016
·
2 min read
Biotech Bay
Novartis AG May Be Too Generic
October 24, 2016
·
1 min read
Biotech Bay
Novartis AG Taps Facebook Live Event To Promote Heart Failure Drugs
October 20, 2016
·
1 min read
Business
Former Novartis AG CAR-T Scientist Jumps to TxCell to Lead CAR-Treg Research Programs
October 14, 2016
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
July 2, 2026
·
7 min read
Press Releases
Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies
June 24, 2026
·
2 min read
Press Releases
Novartis Canada and SP Quebec Celebrate 16 Years of Partnership Through Annual MS Tri-Challenge Fundraiser
June 24, 2026
·
4 min read
Press Releases
FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin
June 17, 2026
·
2 min read
Press Releases
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
June 12, 2026
·
11 min read
Press Releases
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
June 11, 2026
·
8 min read
Press Releases
Orionis Biosciences Announces Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines
June 10, 2026
·
2 min read
Press Releases
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
June 8, 2026
·
6 min read
Press Releases
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
June 4, 2026
·
11 min read
Press Releases
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
June 4, 2026
·
10 min read
